PCOS phenotype focus: phenotype D under the magnifying glass
SH Myers, M Montanino Oliva, M Nordio… - Archives of Gynecology …, 2024 - Springer
Polycystic ovary syndrome (PCOS) is defined as the combination of polycystic morphology,
hyperandrogenism, and ovulatory disruption; this heterogeneity presents a conundrum for …
hyperandrogenism, and ovulatory disruption; this heterogeneity presents a conundrum for …
Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy
S Matsuyama, S Whiteside, SY Li - International Journal of Molecular …, 2024 - mdpi.com
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder in women of
reproductive age, affecting 5–15% globally with a large proportion undiagnosed. This review …
reproductive age, affecting 5–15% globally with a large proportion undiagnosed. This review …
Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target
Simple Summary Breast cancer is one of the most commonly diagnosed malignancies in
women and is also a leading cause of cancer related death. Estrogens play crucial roles in …
women and is also a leading cause of cancer related death. Estrogens play crucial roles in …
Decoding connections in the European population: serum uric acid, sex hormone-binding globulin, total testosterone, estradiol, and female infertility–advanced …
Z Tan, J Shen, Y Huang, J Li, M Ding, A Sun… - Frontiers in …, 2024 - frontiersin.org
Background Despite observational links between serum uric acid (SUA), sex hormone-
related phenotypes, and female infertility, the causality behind these associations remains …
related phenotypes, and female infertility, the causality behind these associations remains …
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis
X Guo, Y Yao, T Wang, J Wu, R Jiang - Hypertension in Pregnancy, 2024 - Taylor & Francis
Background Polycystic ovary syndrome (PCOS) is a metabolic and reproductive disorder.
Current research findings present conflicting views on the effects of different PCOS …
Current research findings present conflicting views on the effects of different PCOS …
[PDF][PDF] Характеристики экспрессии протеомных маркеров у женщин с «тонким» эндометрием и их значение для терапевтических эффектов использования …
НВ Аганезова, СС Аганезов, КЭ Гогичашвили - Гинекология, 2024 - omnidoctor.ru
Аннотация Цель. Проанализировать взаимосвязи между экспрессией протеомных
маркеров эндометриальной рецептивности [рецепторов эстрогенов (ER) и …
маркеров эндометриальной рецептивности [рецепторов эстрогенов (ER) и …
Harnessing Technology to Revolutionize Personalized Therapies for Metrorrhagia
TA Addissouky - Archives of Obstetrics and Gynaecology, 2024 - scientificarchives.com
Background: Metrorrhagia is defined as irregular uterine bleeding occurring between normal
menstrual cycles. Unlike normal menstruation, metrorrhagia is irregular in frequency …
menstrual cycles. Unlike normal menstruation, metrorrhagia is irregular in frequency …
Síndrome dos ovários policísticos: análise de uma década de avanços e perspectivas-uma revisão abrangente da síndrome dos ovários policísticos
C Santiago - 2023 - repositorio.ufrn.br
RESUMO A SOP é uma prevalente condição endócrina que afeta mulheres, impactando a
homeostase metabólica e o sistema cardiovascular. Este estudo revisa os múltiplos critérios …
homeostase metabólica e o sistema cardiovascular. Este estudo revisa os múltiplos critérios …
Characteristics of expression of proteomic markers in women with “thin” endometrium and their importance for the therapeutic effects of the use of exogenous estradiol …
NV Aganezova, SS Aganezov… - Gynecology, 2024 - gynecology.orscience.ru
Aim. To analyze the relationship between the expression of proteomic markers [estrogen
(ER) and progesterone (PR) receptors, LIF, FOXA1, FOXA2] of endometrial receptivity and …
(ER) and progesterone (PR) receptors, LIF, FOXA1, FOXA2] of endometrial receptivity and …